Search Results - "Wynne, Abigail"

Refine Results
  1. 1

    Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner by Hausenloy, Derek J, Whittington, Hannah J, Wynne, Abigail M, Begum, Shah S, Theodorou, Louise, Riksen, Niels, Mocanu, Mihaela M, Yellon, Derek M

    Published in Cardiovascular diabetology (22-10-2013)
    “…The dipeptidyl peptidase-4 (DPP-4) inhibitors Sitagliptin and Vildagliptin lower blood glucose by augmenting endogenous levels of glucagon-like peptide-1…”
    Get full text
    Journal Article
  2. 2

    Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection by HAUSENLOY, Derek, WYNNE, Abigail, DUCHEN, Michael, YELLON, Derek

    Published in Circulation (New York, N.Y.) (13-04-2004)
    “…Transient (low-conductance) opening of the mitochondrial permeability transition pore (mPTP) may limit mitochondrial calcium load and mediate mitochondrial…”
    Get full text
    Journal Article
  3. 3

    Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening by Bhamra, Gurpreet S., Hausenloy, Derek J., Davidson, Sean M., Carr, Richard D., Paiva, Marta, Wynne, Abigail M., Mocanu, Mihaela M., Yellon, Derek M.

    Published in Basic research in cardiology (01-05-2008)
    “…Background In the majority of studies, metformin has been demonstrated to cardioprotect diabetic patients, the mechanism of which is unclear. We hypothesized…”
    Get full text
    Journal Article
  4. 4

    Preconditioning the diabetic human myocardium by Sivaraman, Vivek, Hausenloy, Derek J., Wynne, Abigail M., Yellon, Derek M.

    Published in Journal of cellular and molecular medicine (01-06-2010)
    “…Our objective was to determine whether human diabetic myocardium is amenable to the cardioprotective actions of ischaemic preconditioning. Human right atrial…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Ischemic preconditioning targets the reperfusion phase by Hausenloy, Derek J, Wynne, Abigail M, Yellon, Derek M

    Published in Basic research in cardiology (01-09-2007)
    “…Emerging studies suggest that signaling during the myocardial reperfusion phase contributes to ischemic preconditioning (IPC). Whether the activation of PKC,…”
    Get full text
    Journal Article
  7. 7

    Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart by Hausenloy, Derek J, Wynne, Abigail M, Mocanu, Mihaela M, Yellon, Derek M

    “…The diabetic heart is resistant to the myocardial infarct-limiting effects of ischemic preconditioning (IPC). This may be in part due to the downregulation of…”
    Get more information
    Journal Article
  8. 8

    Pioglitazone Mimics Preconditioning in the Isolated Perfused Rat Heart: A Role for the Prosurvival Kinases PI3K and P42/44MAPK by Wynne, Abigail M, Mocanu, Mihaela M, Yellon, Derek M

    Published in Journal of cardiovascular pharmacology (01-12-2005)
    “…Ischemic preconditioning, the most powerful protection against infarction, activates PI3Kinase (PI3K)/AKT and P42/44MAPK. Pioglitazone, a thiazolidinedione and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Cardioprotective Actions of Leptin Are Lost in the Zucker Obese (fa/fa) Rat by Dixon, Richard A, Davidson, Sean M, Wynne, Abigail M, Yellon, Derek M, Smith, Christopher C T

    Published in Journal of cardiovascular pharmacology (01-04-2009)
    “…Protection against myocardial ischemia-reperfusion injury, including that induced by leptin, involves activation of the reperfusion injury salvage kinase…”
    Get full text
    Journal Article
  11. 11

    Temporal Changes in Myocardial Salvage Kinases During Reperfusion Following Ischemia : Studies Involving the Cardioprotective Adipocytokine Apelin by SMITH, Christopher C. T, MOCANU, Michaela M, BOWEN, Jonathan, WYNNE, Abigail M, SIMPKIN, James C, DIXON, Richard A, COOPER, Michael B, YELLON, Derek M

    Published in Cardiovascular drugs and therapy (01-12-2007)
    “…Activation of the Reperfusion Injury Salvage Kinase (RISK) pathway, which incorporates phosphatidylinositol-3-OH kinase (PI3K)-Akt/protein kinase B (PKB) and…”
    Get full text
    Journal Article
  12. 12

    Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury by Smith, Christopher C T, Lim, Shiang Y, Wynne, Abigail M, Sivaraman, Vivek, Davidson, Sean M, Mocanu, Mihaela M, Hausenloy, Derek J, Yellon, Derek M

    “…Experimental studies have linked the adipocytokines with acute cardioprotection. Whether the adipocytokine, resistin, confers protection is, however,…”
    Get more information
    Journal Article
  13. 13

    Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury by Simpkin, J. C., Yellon, D. M., Davidson, S. M., Lim, S. Y., Wynne, A. M., Smith, C. C. T.

    Published in Basic research in cardiology (01-11-2007)
    “…Protection against myocardial ischemia-reperfusion (I/R) injury involves activation of phosphatidylinositol-3-OH kinase (PI3K)- Akt/protein kinase B and p44/42…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20